GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted ...

A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the ...

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

Amid ongoing controversy, Sen. Maggie Hassan (D-N.H.) is investigating GSK for replacing a popular asthma inhaler with a ...

Kindly share this postThe manufacturers of the world’s first malaria vaccine are set to slash the price by more than half by ...

The innovative vaccine delivery system can provide full course of immunisation - both initial and booster doses.

Oxford researchers have developed programmable microcapsules to deliver vaccines in stages, potentially eliminating the need ...

New UK support will see millions of children, including in Ghana, vaccinated against some of the world rsquo;s deadliest ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world’s first malaria vaccine for children ‘RTS,S’ developed by GSK, PATH and partners, by more than ...

Bharat Biotech and GSK plc will significantly reduce the price of their malaria vaccine, Mosquirix, to under $5 per dose by ...

HYDERABAD: Bharat Biotech International Limited (BBIL) and GSK plc on Wednesday announced a price reduction on the world’s first malaria vaccine, RTS.S. The vac ...